Press Enter to search · Esc to close
A large Chinese cohort study suggests that losing both thinking power and lean mass together carries a sharper mortality signal than either alone — and points toward a combined training plan.
A new analysis of 5,654 American adults links a protein called Klotho to how fast our bodies are actually aging — and it's the kind of signal that nudges Klotho out of the lab and toward your next bloodwork panel.
A harmonised analysis of five major UK and US cohorts finds that the midlife risk factors for early-onset dementia don't always track the familiar late-onset picture — a moderate but consequential signal for how we screen.
Two new papers reframe age-related muscle loss as a downstream effect of chronic inflammation, immune aging, and a restless gut. Protein shakes alone won't cut it.
A 13,422-person analysis hints the brain-friendly eating pattern may also help older adults hold onto muscle and physical function.
A long-running Japanese cohort and a fresh Indian prevalence study complicate the metabolic-syndrome story — pointing to the components that actually move the mortality needle.
A new review in Atherosclerosis argues that the air you breathe, the noise outside your window, and the climate you live in may shape cardiovascular risk more than the contents of your medicine cabinet.
A new mechanistic review argues that after 50, the cardiovascular system and the skeletal muscle system age as one. Protecting muscle, in other words, may be vascular medicine in disguise.
Two new studies sharpen the picture of chronic low-grade inflammation in aging — one points to a routine blood ratio, the other to a specific gut microbe coaxed by ginseng. Neither is a prescription. Both are worth watching.
Computational design is pushing peptide therapeutics into oncology, infectious disease, and antimicrobial resistance. The early signals are real — and the caveats matter.